Perinatal Substance Use

Which is Safer for the Treatment of Opioid Use Disorder During Pregnancy: Buprenorphine or Methadone?

In this large cohort study analyzing data from publicly insured Medicaid beneficiaries, the overall risk of malformations was lower with buprenorphine than with methadone.

By |2024-05-16T06:55:02-04:00March 6th, 2024|Opioids, Perinatal Substance Use, Treatment|Comments Off on Which is Safer for the Treatment of Opioid Use Disorder During Pregnancy: Buprenorphine or Methadone?

Buprenorphine or Methadone: Which One is Better for the Treatment of Opioid Use Disorder in Pregnancy?

Treatment with buprenorphine versus methadone during pregnancy is associated with lower risk of preterm birth, low birth weight, small size for gestational age, and NAS.

By |2022-12-29T18:33:13-04:00December 22nd, 2022|Opioids, Perinatal Substance Use, Pregnancy & Medications, Treatment|Comments Off on Buprenorphine or Methadone: Which One is Better for the Treatment of Opioid Use Disorder in Pregnancy?

Risk of Neonatal Opioid Withdrawal Syndrome More Common with Certain Opioids: Implications for Women with Opioid Use Disorder

More infants who were exposed to strong agonists and opioids with long half-lives, including methadone, developed neonatal opioid withdrawal syndrome.

By |2022-09-27T09:13:32-04:00September 27th, 2022|Opioids, Perinatal Substance Use, Prevalence & Risk Factors|Comments Off on Risk of Neonatal Opioid Withdrawal Syndrome More Common with Certain Opioids: Implications for Women with Opioid Use Disorder
Go to Top